Report cover image

Flooring Market Size, Share & Trends Analysis Report By Product (Ceramic Tiles, Porcelain Tiles, Carpet, Vinyl, Wood & Laminate), By Application (Residential, Commercial, Industrial), By Region, And Segment Forecasts, 2026 - 2033

Publisher Grand View Research
Published Dec 10, 2025
Length 101 Pages
SKU # GV20723787

Description

Flooring Market Summary

The global flooring market size was estimated at USD 385.6 billion in 2025 and is projected to reach USD 634.8 billion by 2033, growing at a CAGR of 6.4% from 2026 to 2033. Increasing demand for aesthetic, superior, and durable floor covering solutions and changing consumer trends in floor design are aiding the growth of the flooring industry over the past few years.

The expansion of offices & workspaces, improving consumer Industrial, and rapid urbanization are factors that have also contributed to the market growth. The fast-paced infrastructural development owing to the rising population in developing countries further contributes to the growth of the flooring industry.

The growing disposable income has resulted in increased investments for comfort in residential buildings. In addition, the continuous growth of high-end residential housing structures and the subsequent and growing preference for single-family housing structures are driving the demand for the market.

The advancements in easy-to-install techniques, the availability of innovative construction solutions, and the rising demand for environmentally sustainable products are expected to drive the industry’s growth. The stringent regulatory framework during the production, usage, implementation, and recycling stages is also expected to boost market growth. Furthermore, consumer preferences for aesthetically improved designs, textures, and colors, as well as low-maintenance and easy-to-install floorings, are expected to drive market growth. The growing desire for comfort and privacy as a result of noisier surroundings has increased the demand for insulation in the market, as well-insulated floors create a better acoustic environment. As a result, demand for floor insulation has increased, supporting market growth.

Global Flooring Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global flooring market report based on product, application, and region.
  • Product Outlook (Volume, Million Square Meters; Revenue, USD Million, 2021 - 2033)
  • Ceramic Tiles
  • Vitrified (Porcelain) Tiles
  • Carpet
  • Vinyl
  • Luxury Vinyl Tiles (LVT)
  • Vinyl Composite Tile (VCT)
  • Linoleum/Rubber
  • Wood & Laminate
  • Other Flooring Materials
  • Application Outlook (Volume, Million Square Meters; Revenue, USD Million, 2021 - 2033)
  • Residential
  • Commercial
  • Industrial
  • Regional Outlook (Volume, Million Square Meters; Revenue, USD Million, 2021 - 2033)
  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Romania
  • Czech Republic
  • Portugal
  • Ukraine
  • Slovakia
  • Hungary
  • Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Philippines
  • Vietnam
  • Central & South America
  • Brazil
  • Argentina
  • Peru
  • Colombia
  • Chile
  • Middle East & Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Egypt
  • Qatar
  • South Africa
  • Morocco
Please note The report will be delivered in 2-3 business days upon order notification.

Table of Contents

101 Pages
Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Technology Segment
1.2.2. Delivery Method Segment
1.2.3. Application Segment
1.2.4. Mode Segment
1.2.5. End Use Segment
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. GVR’s internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
1.10.1. Objective 1
1.10.2. Objective 2
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Snapshot
2.3. Competitive Insights Landscape
Chapter 3. Genome Editing Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook.
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. Success in pre-clinical models drives demand for genome editing therapeutics
3.2.1.2. Rising competition amongst market participants for business development
3.2.1.3. Easy editing solutions for the development of therapeutics for a broad range of diseases
3.2.1.4. Increasing demand for synthetic genes and genetically modified organisms
3.2.1.5. Technological advancements in gene editing technologies
3.2.1.6. Rising adoption in agricultural biotechnology
3.2.2. Market restraint analysis
3.2.2.1. Challenges concerning clinical translation
3.2.2.2. Regulatory, scientific, and ethical challenges regarding the use of genetically modified products
3.2.2.3. Off-target effects of CRISPR technology
3.3. Genome Editing Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.2. PESTEL Analysis
3.3.3. COVID-19 Impact Analysis
Chapter 4. Genome Editing Market: Technology Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Global Genome Editing Market Technology Movement Analysis
4.3. Global Genome Editing Market Size & Trend Analysis, by Technology, 2021 to 2033 (USD Million)
4.4. (CRISPR)/Cas9
4.4.1. (CRISPR)/Cas9 market estimates and forecasts 2021 to 2033 (USD Million)
4.5. TALENs/MegaTALs
4.5.1. TALENs/MegaTALs market estimates and forecasts 2021 to 2033 (USD Million)
4.6. ZFN
4.6.1. ZFN market estimates and forecasts 2021 to 2033 (USD Million)
4.7. Meganuclease
4.7.1. Meganuclease market estimates and forecasts 2021 to 2033 (USD Million)
4.8. Others
4.8.1. Others market estimates and forecasts 2021 to 2033 (USD Million)
Chapter 5. Genome Editing Market: Delivery Method Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. Global Genome Editing Market Delivery Method Movement Analysis
5.3. Global Genome Editing Market Size & Trend Analysis, by Delivery Method, 2021 to 2033 (USD Million)
5.4. Ex Vivo
5.4.1. Ex vivo market estimates and forecasts 2021 to 2033 (USD Million)
5.5. In-Vivo
5.5.1. In-vivo market estimates and forecasts 2021 to 2033 (USD Million)
Chapter 6. Genome Editing Market: Application Estimates & Trend Analysis
6.1. Segment Dashboard
6.2. Global Genome Editing Market Application Movement Analysis
6.3. Global Genome Editing Market Size & Trend Analysis, by Application, 2021 to 2033 (USD Million)
6.4. Genetic Engineering
6.4.1. Genetic Engineering market estimates and forecasts 2021 to 2033 (USD Million)
6.4.2. Cell Line Engineering
6.4.2.1. Cell line engineering market estimates and forecasts 2021 to 2033 (USD Million)
6.4.3. Animal Genetic Engineering
6.4.3.1. Animal genetic engineering market estimates and forecasts 2021 to 2033 (USD Million)
6.4.4. Plant Genetic Engineering
6.4.4.1. Plant genetic engineering market estimates and forecasts 2021 to 2033 (USD Million)
6.4.5. Others
6.4.5.1. Others market estimates and forecasts 2021 to 2033 (USD Million)
6.5. Clinical Applications
6.5.1. Clinical applications market estimates and forecasts 2021 to 2033 (USD Million)
6.5.2. Diagnostics Development
6.5.2.1. Diagnostics development market estimates and forecasts 2021 to 2033 (USD Million)
6.5.3. Therapy Development
6.5.3.1. Therapy development market estimates and forecasts 2021 to 2033 (USD Million)
Chapter 7. Genome Editing Market: Mode Estimates & Trend Analysis
7.1. Segment Dashboard
7.2. Global Genome Editing Market Mode Movement Analysis
7.3. Global Genome Editing Market Size & Trend Analysis, by Mode, 2021 to 2033 (USD Million)
7.4. Contract
7.4.1. Contract market estimates and forecasts 2021 to 2033 (USD Million)
7.5. In-house
7.5.1. In-house market estimates and forecasts 2021 to 2033 (USD Million)
Chapter 8. Genome Editing Market: End Use Estimates & Trend Analysis
8.1. Segment Dashboard
8.2. Global Genome Editing Market End-Use Movement Analysis
8.3. Global Genome Editing Market Size & Trend Analysis, by End-Use, 2021 to 2033 (USD Million)
8.4. Biotechnology and pharmaceutical companies
8.4.1. Biotechnology and pharmaceutical companies market estimates and forecasts 2021 to 2033 (USD Million)
8.5. Academic and government research institutes
8.5.1. Academic and government research institutes market estimates and forecasts 2021 to 2033 (USD Million)
8.6. Contract research organizations
8.6.1. Contract research organizations market estimates and forecasts 2021 to 2033 (USD Million)
Chapter 9. Genome Editing Market: Regional Estimates & Trend Analysis
9.1. Regional Market Share Analysis, 2025 & 2033
9.2. Regional Market Dashboard
9.3. Market Size, & Forecasts Trend Analysis, 2021 to 2033:
9.4. North America
9.4.1. U.S.
9.4.1.1. Key country dynamics
9.4.1.2. Regulatory framework
9.4.1.3. Target disease prevalence
9.4.1.4. Competitive scenario
9.4.1.5. U.S. market estimates and forecasts 2021 to 2033 (USD Million)
9.4.2. Canada
9.4.2.1. Key country dynamics
9.4.2.2. Regulatory framework
9.4.2.3. Target disease prevalence
9.4.2.4. Competitive scenario
9.4.2.5. Canada market estimates and forecasts 2021 to 2033 (USD Million)
9.4.3. Mexico
9.4.3.1. Key country dynamics
9.4.3.2. Regulatory framework
9.4.3.3. Target disease prevalence
9.4.3.4. Competitive scenario
9.4.3.5. Mexico market estimates and forecasts 2021 to 2033 (USD Million)
9.5. Europe
9.5.1. UK
9.5.1.1. Key country dynamics
9.5.1.2. Regulatory framework
9.5.1.3. Target disease prevalence
9.5.1.4. Competitive scenario
9.5.1.5. UK market estimates and forecasts 2021 to 2033 (USD Million)
9.5.2. Germany
9.5.2.1. Key country dynamics
9.5.2.2. Regulatory framework
9.5.2.3. Target disease prevalence
9.5.2.4. Competitive scenario
9.5.2.5. Germany market estimates and forecasts 2021 to 2033 (USD Million)
9.5.3. France
9.5.3.1. Key country dynamics
9.5.3.2. Regulatory framework
9.5.3.3. Target disease prevalence
9.5.3.4. Competitive scenario
9.5.3.5. France market estimates and forecasts 2021 to 2033 (USD Million)
9.5.4. Italy
9.5.4.1. Key country dynamics
9.5.4.2. Regulatory framework
9.5.4.3. Target disease prevalence
9.5.4.4. Competitive scenario
9.5.4.5. Italy market estimates and forecasts 2021 to 2033 (USD Million)
9.5.5. Spain
9.5.5.1. Key country dynamics
9.5.5.2. Regulatory framework
9.5.5.3. Target disease prevalence
9.5.5.4. Competitive scenario
9.5.5.5. Spain market estimates and forecasts 2021 to 2033 (USD Million)
9.5.6. Norway
9.5.6.1. Key country dynamics
9.5.6.2. Regulatory framework
9.5.6.3. Target disease prevalence
9.5.6.4. Competitive scenario
9.5.6.5. Norway market estimates and forecasts 2021 to 2033 (USD Million)
9.5.7. Sweden
9.5.7.1. Key country dynamics
9.5.7.2. Target disease prevalence
9.5.7.3. Regulatory framework
9.5.7.4. Competitive scenario
9.5.7.5. Sweden market estimates and forecasts 2021 to 2033 (USD Million)
9.5.8. Denmark
9.5.8.1. Key country dynamics
9.5.8.2. Regulatory framework
9.5.8.3. Target disease prevalence
9.5.8.4. Competitive scenario
9.5.8.5. Denmark market estimates and forecasts 2021 to 2033 (USD Million)
9.6. Asia Pacific
9.6.1. Japan
9.6.1.1. Key country dynamics
9.6.1.2. Regulatory framework
9.6.1.3. Target disease prevalence
9.6.1.4. Competitive scenario
9.6.1.5. Japan market estimates and forecasts 2021 to 2033 (USD Million)
9.6.2. China
9.6.2.1. Key country dynamics
9.6.2.2. Regulatory framework
9.6.2.3. Target disease prevalence
9.6.2.4. Competitive scenario
9.6.2.5. China market estimates and forecasts 2021 to 2033 (USD Million)
9.6.3. India
9.6.3.1. Key country dynamics
9.6.3.2. Regulatory framework
9.6.3.3. Competitive scenario
9.6.3.4. Target disease prevalence
9.6.3.5. India market estimates and forecasts 2021 to 2033 (USD Million)
9.6.4. Australia
9.6.4.1. Key country dynamics
9.6.4.2. Regulatory framework
9.6.4.3. Target disease prevalence
9.6.4.4. Competitive scenario
9.6.4.5. Australia market estimates and forecasts 2021 to 2033 (USD Million)
9.6.5. South Korea
9.6.5.1. Key country dynamics
9.6.5.2. Regulatory framework
9.6.5.3. Target disease prevalence
9.6.5.4. Competitive scenario
9.6.5.5. South Korea market estimates and forecasts 2021 to 2033 (USD Million)
9.6.6. Thailand
9.6.6.1. Key country dynamics
9.6.6.2. Target disease prevalence
9.6.6.3. Regulatory framework
9.6.6.4. Competitive scenario
9.6.6.5. Thailand market estimates and forecasts 2021 to 2033 (USD Million)
9.7. Latin America
9.7.1. Brazil
9.7.1.1. Key country dynamics
9.7.1.2. Regulatory framework
9.7.1.3. Target disease prevalence
9.7.1.4. Competitive scenario
9.7.1.5. Brazil market estimates and forecasts 2021 to 2033 (USD Million)
9.7.2. Argentina
9.7.2.1. Key country dynamics
9.7.2.2. Regulatory framework
9.7.2.3. Target disease prevalence
9.7.2.4. Competitive scenario
9.7.2.5. Argentina market estimates and forecasts 2021 to 2033 (USD Million)
9.8. MEA
9.8.1. South Africa
9.8.1.1. Key country dynamics
9.8.1.2. Regulatory framework
9.8.1.3. Competitive scenario
9.8.1.4. Target disease prevalence
9.8.1.5. South Africa market estimates and forecasts 2021 to 2033 (USD Million)
9.8.2. Saudi Arabia
9.8.2.1. Key country dynamics
9.8.2.2. Regulatory framework
9.8.2.3. Target disease prevalence
9.8.2.4. Competitive scenario
9.8.2.5. Saudi Arabia market estimates and forecasts 2021 to 2033 (USD Million)
9.8.3. UAE
9.8.3.1. Key country dynamics
9.8.3.2. Regulatory framework
9.8.3.3. Target disease prevalence
9.8.3.4. Competitive scenario
9.8.3.5. UAE market estimates and forecasts 2021 to 2033 (USD Million)
9.8.4. Kuwait
9.8.4.1. Key country dynamics
9.8.4.2. Regulatory framework
9.8.4.3. Target disease prevalence
9.8.4.4. Competitive scenario
9.8.4.5. Kuwait market estimates and forecasts 2021 to 2033 (USD Million)
Chapter 10. Competitive Landscape
10.1. Company/Competition Categorization
10.2. Strategy Mapping
10.3. Company Market Position Analysis, 2025
10.4. Company Profiles/Listing
10.4.1. Merck KGaA
10.4.1.1. Company overview
10.4.1.2. Financial performance
10.4.1.3. Product benchmarking
10.4.1.4. Strategic initiatives
10.4.2. Takara Bio Inc.
10.4.2.1. Company overview
10.4.2.2. Financial performance
10.4.2.3. Product benchmarking
10.4.2.4. Strategic initiatives
10.4.3. Revvity, Inc.
10.4.3.1. Company overview
10.4.3.2. Financial performance
10.4.3.3. Product benchmarking
10.4.3.4. Strategic initiatives
10.4.4. Danaher Corporation
10.4.4.1. Company overview
10.4.4.2. Financial performance
10.4.4.3. Product benchmarking
10.4.4.4. Strategic initiatives
10.4.5. GenScript
10.4.5.1. Company overview
10.4.5.2. Financial performance
10.4.5.3. Product benchmarking
10.4.5.4. Strategic initiatives
10.4.6. New England Biolabs
10.4.6.1. Company overview
10.4.6.2. Financial performance
10.4.6.3. Product benchmarking
10.4.6.4. Strategic initiatives
10.4.7. Charles River Laboratories
10.4.7.1. Company overview
10.4.7.2. Financial performance
10.4.7.3. Product benchmarking
10.4.7.4. Strategic initiatives
10.4.8. Eurofins Scientific
10.4.8.1. Company overview
10.4.8.2. Financial performance
10.4.8.3. Product benchmarking
10.4.8.4. Strategic initiatives
10.4.9. Lonza
10.4.9.1. Company overview
10.4.9.2. Financial performance
10.4.9.3. Product benchmarking
10.4.9.4. Strategic initiatives
10.4.10. Thermo Fisher Scientific, Inc.
10.4.10.1. Company overview
10.4.10.2. Financial performance
10.4.10.3. Product benchmarking
10.4.10.4. Strategic initiatives

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us